American Pain Society, Principles
of analgesic use in the treatment of acute pain and cancer
pain: a concise guide to medical practice, Skokie, IL, American
Pain Society; 1992.
Bonica JJ, The Management of Pain, 2nd Ed., Lea
and Febiger, Philadelphia, 1990.
Bruera E, Brenneis C, Patterson AH, Use of methylphenidate
as an adjuvant to narcotic analgesics in patients with advanced cancer,
J Pain and Symptom Management, 1989; 4(l):3-6.
Campora E, Merlini L, Pace M, et al, The incidence
of narcotic-induced emesis, J Pain and Symptom Management, 1991; 6:428-30.
Cancer Pain Relief, 2nd Ed, World Health
Organization, Geneva, 1996.
Chapman CR, Hill HF, Prolonged morphine self-administration
and addiction liability, Cancer,1989; 63:1636-44.
Cherny NI, Portenoy RK, Cancer pain management:
current strategy, Cancer (Supplement), 1993; 72:3394-3415.
Foley KM, Controversies in cancer pain: medical
perspective, Cancer, 1989; 63:2257-65.
Foley KM, Pain syndromes in Patients with Cancer, Medical Clinics of
No. America, 71(2): 169-184; 1987
Foley KM, The treatment of cancer pain, NEJM, 1985a: 313(2):84-95.
Hester NO, Barcus CS, Assessment and management
of pain in children, Pediatric: Nurs Update, 1986; 1:18.
Houde RW, Analgesic effectiveness of the narcotic
agonist-antagonists, Br J Clin Pharmacology, 1979; 7:297S-308S.
Jaycox A, Carr DB, Payne R, et al. Management
of Cancer Pain, Clinical Practice Guideline No. 9, Agency for Health
Care Policy and Research, US Department of Health and Human Services,
Kaiki RK, Foley KM, Intrussi CE, et al, Central
nervous system excitatory effects of meperidine in cancer patients,
Ann Neurol, 1983; 13:180-5. 28 i.b.i.d. ref. 1, p. 88.
Levy MH, Pharmacological treatment of cancer pain,
NEJM, 1996; 335(15):1124-1132.
Mayer DJ, Mao J, Price DD, The development of morphine
tolerance and dependence is associated with the translocation of protein
kinase C, Pain, 1995; 61:365-74.
Pirson Y, van Ypersele de Strihou C, Renal side
effects of nonsteriodal anti-inflammatory drugs: clinical relevance,
Am J Kidney Dis, 1986; 8:337-344.
Portenoy RK, Hagen NA, Breakthrough pain: definition,
prevalence, and characteristics, Pain, 1990; 41:273-81.
Portenoy RK, Opioid analgesics, in Portenoy RK, Kanner RM, Pain Management:
Theory and Practice, FA Davis & Co, Philadelphia, 1996.
Reisine T, Pasternak G, Opioid analgesics and
antagonists, in Hardman JG, Limbird LE, eds., Goodman and Gilman's The
Pharmacological Basis of Therapeutics, 9th Ed., Pergamon Press, New
York,1996, Chap 23.
Schuster CR, Does treatment of cancer pain with
narcotics produce junkies?in Hill CS, Fields WS, Drug treatment of cancer
pain in a drug oriented society: advances in pain research and therapy,
Vol 11, Raven Press, New York, 10989, ppl-3
Seef Lb, Cucchierini BA, Zimmerman Hl, Benjamin S,
Acetaminophen hepatotoxicity in alcoholics, Ann Int Med, 1986; 104:339-404.
Twycross RG, Clinical Experience with Diamorphine in
Advanced Malignant Pain, Int Journal of Clinical Pharmacology, 1974; 9:184-198
Walsh TD, Prevention of opioid side effects, J
Pain and Symptom Management, 1990; 5:363-7.